Parkman Healthcare Partners LLC Decreases Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Parkman Healthcare Partners LLC trimmed its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 38.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 277,471 shares of the company’s stock after selling 172,529 shares during the quarter. Parkman Healthcare Partners LLC owned 0.07% of LifeStance Health Group worth $2,045,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Blue Trust Inc. increased its position in shares of LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after acquiring an additional 2,122 shares during the last quarter. R Squared Ltd purchased a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $80,000. Ameriprise Financial Inc. purchased a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $87,000. Cibc World Markets Corp purchased a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $96,000. Finally, Forum Financial Management LP purchased a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $110,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

LFST has been the subject of several research reports. Canaccord Genuity Group initiated coverage on LifeStance Health Group in a report on Thursday, April 3rd. They set a “buy” rating and a $8.00 price objective for the company. KeyCorp initiated coverage on LifeStance Health Group in a report on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price objective for the company. Finally, William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $8.30.

Insiders Place Their Bets

In related news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 3.20% of the company’s stock.

LifeStance Health Group Stock Up 0.3%

NASDAQ LFST opened at $5.87 on Wednesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market capitalization of $2.28 billion, a PE ratio of -22.58 and a beta of 1.30. LifeStance Health Group, Inc. has a 1 year low of $4.64 and a 1 year high of $8.61. The business’s 50-day moving average is $6.62 and its 200 day moving average is $7.24.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.